Clinical applications of urinary organic acids. part 1: Detoxification markers

Alternative Medicine Review

Volumn 13, Issue 3, 2008, Pages 205-215

  Lord, Richard S ^a,b   Bralley, J Alexander ^c  

^a Metametrix Institute

^b Metametrix Institute   (United States)

^c Metametrix Clinical Laboratory

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYBUTYRATE DEHYDROGENASE; 2 METHYLHIPPURATE; AMMONIA; BENZOIC ACID; BIOCHEMICAL MARKER; CARBOXYLIC ACID; GLUTATHIONE; GLYCINE; HIPPURIC ACID; OROTIC ACID; PANTOTHENIC ACID; PYROGLUTAMIC ACID; SACCHARIC ACID; SULFATE; UNCLASSIFIED DRUG; XYLENE;

CONJUGATION; DETOXIFICATION; GLUTATHIONE METABOLISM; HYPERAMMONEMIA; REVIEW; UPREGULATION; UREA CYCLE; URINALYSIS;

BENZOATES; BIOLOGICAL MARKERS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; GLUCARIC ACID; HIPPURATES; HUMANS; HYDROXYBUTYRATES; METABOLIC DETOXICATION, DRUG; OROTIC ACID; PYRROLIDONECARBOXYLIC ACID; SULFATES;

EID: 53549091032     PISSN: 10895159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (77)

1. Inoue O, Seiji K, Suzuki T, et al. Simultaneous determination of hippuric acid, o-, m-, and p-methylhippuric acid, phenylglyoxylic acid, and mandelic acid by HPLC. Bull Environ Contam Toxicol 1991;47:204-210.
2. Tardif R, Brodeur J, Plaa GL. Simultaneous high-performance liquid chromatographic analysis of hippuric acid and ortho-, meta-, and para-methylhippuric acids in urine. J Anal Toxicol 1989;13:313-316.
3. Triebig G, Schaller KH, Weltle D. Neurotoxicity of solvent mixtures in spray painters. I. Study design, workplace exposure, and questionnaire. Int Arch Occup Environ Health 1992;64:353-359.
4. Lundberg I, Sollenberg J. Correlation of xylene exposure and methyl hippuric acid excretion in urine among paint industry workers. Scand J Work Environ Health 1986;12:149-153.
5. Inoue O, Seiji K, Kawai T, et al. Excretion of methylhippuric acids in urine of workers exposed to a xylene mixture: comparison among three xylene isomers and toluene. Int Arch Occup Environ Health 1993;64:533-539.
6. Bishop MJ, Crow BS, Kovalcik KD, et al. Quantification of urinary zwitterionic organic acids using weak-anion exchange chromatography with tandem MS detection. J Chromatogr B Analyt Technol Biomed Life Sci 2007;848:303-310.
7. Lee KJ, Lee JJ, Moon DC. Application of micellar electrokinetic capillary chromatography for monitoring of hippuric and methylhippuric acid in human urine. Electrophoresis 1994;15:98-102.
8. van der Heiden C, Wauters EA, Duran M, et al. Gas chromatographic analysis of urinary tyrosine and phenylalanine metabolites in patients with gastrointestinal disorders. Clin Chim Acta 1971;34:289-296.
9. Goodwin BL, Ruthven CR, Sandler M. Gut flora and the origin of some urinary aromatic phenolic compounds. Biochem Pharmacol 1994;47:2294-2297.
10. Scalbert A, Morand C, Manach C, Remesy C. Absorption and metabolism of polyphenols in the gut and impact on health. Biomed Pharmacother 2002;56:276-282.
11. de Luca C, Passi S, Quattrucci E. Simultaneous determination of sorbic acid, benzoic acid and parabens in foods: a new gas chromatography-mass spectrometry technique adopted in a survey on Italian foods and beverages. Food Addit Contam 1995;12:1-7.
12. Quick A. The study of benzoic acid conjugation in the dog with a direct quantitative method for hippuric acid. J Biol Chem 1934:477-490.
13. Temellini A, Mogavero S, Giulianotti PC, et al. Conjugation of benzoic acid with glycine in human liver and kidney: a study on the interindividual variability. Xenobiotica 1993;23:1427-1433.
14. Visek WJ. Nitrogen-stimulated orotic acid synthesis and nucleotide imbalance. Cancer Res 1992;52:2082s-2084s.
15. Nagasaka H, Yorifuji T, Murayama K, et al. Effects of arginine treatment on nutrition, growth and urea cycle function in seven Japanese boys with late-onset ornithine transcarbamylase deficiency. Eur J Pediatr 2006;165:618-624.
16. Gilchrist JM, Coleman RA. Ornithine transcarbamylase deficiency: adult onset of severe symptoms. Ann Intern Med 1987;106:556-558.
17. Takanashi J, Kurihara A, Tomita M, et al. Distinctly abnormal brain metabolism in late-onset ornithine transcarbamylase deficiency. Neurology 2002;59:210-214.
18. Milner JA. Metabolic aberrations associated with arginine deficiency. J Nutr 1985;115:516-523.
19. Milner JA, Visek WJ. Orotate, citrate, and urea excretion in rats fed various levels of arginine. Proc Soc Exp Biol Med 1974;147:754-759.
20. Lizarralde G, Mazzocco VE, Flink EB. Magnesium deficiency and urea cycle enzymes in rat liver. Proc Soc Exp Biol Med 1967;126:249-251.
21. Whang R, Ryan MP, Aikawa JK. Magnesium deficiency: a cause of reversible renal failure. Lancet 1973;1:135-136.
22. Goksel BK, Torun D, Karaca S, et al. Is low blood magnesium level associated with hemodialysis headache? Headache 2006;46:40-45.
23. Klein CJ, Moser-Veillon PB, Schweitzer A, et al. Magnesium, calcium, zinc, and nitrogen loss in trauma patients during continuous renal replacement therapy. JPEN J Parenter Enteral Nutr 2002;26:77-92;discussion 92-93.
24. Adamek MU, Brass H, Karbach U. A rare cause of hepatic coma. Med Klin (Munich) 2001;96:234-237. [Article in German]
25. Liu Q Duan ZP, Ha DK, et al. Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology 2004;39:1441-1449.
26. Van Laethem JL, Gay F, Franck N, Van Gossum A. Hyperammoniemic coma in a patient with ureterosigmoidostomy and normal liver function. Dig Dis Sci 1992;37:1754-1756.
27. Nelson J, Qureshi IA, Ghole VS, Deshmukh DR. Regulation of orotic acid biosynthesis and excretion induced by oral glutamine administration in mice. Biochem Med Metab Biol 1993;49:338-350.
28. Boon L, Geerts WJ, Jonker A, et al. High protein diet induces pericentral glutamate dehydrogenase and ornithine aminotransferase to provide sufficient glutamate for pericentral detoxification of ammonia in rat liver lobules. Histochem Cell Biol 1999;111:445-452.
29. Marsh CA. Biosynthesis of d-glucaric acid in mammals: a free-radical mechanism? Carbohydr Res 1986;153:119-131.
30. Anders M, Dekant W, eds. Conjugation-Dependent Carcinogenicity and Toxicity of Foreign Compounds. New York, NY: Academic Press; 1994.
31. Hanausek M, Walaszek Z, Slaga TJ. Detoxifying cancer causing agents to prevent cancer. Integr Cancer Ther 2003;2:139-144.
32. Kim DH, Jin YH. Intestinal bacterial beta-glucuronidase activity of patients with colon cancer. Arch Pharm Res 2001;24:564-567.
33. Walaszek Z, Szemraj J, Narog M, et al. Metabolism, uptake, and excretion of a d-glucaric acid salt and its potential use in cancer prevention. Cancer Detect Prev 1997;21:178-190.
34. Mulder GJ. Conjugation Reactions in Drug Metabolism: An Integrated Approach. Bristol, PA: Taylor & Francis Ltd.; 1990.
35. Timbrell J. Principles of Biochemical Toxicology, 3rd ed. Philadelphia, PA: Taylor & Francis, Ltd.; 2000.
36. Hunter J, Maxwell JD, Carrella M, et al. Urinary d-glucaric-acid excretion as a test for hepatic enzyme induction in man. Lancet 1971;1:572-575.
37. Hunter J, Maxwell JD, Stewart DA, Williams R. Urinary d-glucaric acid excretion and total liver content of cytochrome P-450 in guinea-pigs: relationship during enzyme induction and following inhibition of protein synthesis. Biochem Pharmacol 1973;22:743-747.
38. Sandle LN, Braganza JM. An evaluation of the low-pH enzymatic assay of urinary d-glucaric acid, and its use as a marker of enzyme induction in exocrine pancreatic disease. Clin Chim Acta 1987;162:245-256. Erratum in Clin Chim Acta 1990;188:279.
39. Perry W, Jenkins MV. Note on the enzyme assay for urinary d-glucaric acid and correlation with rifampicin-induced mixed function oxidase activity. Int J Clin Pharmacol Ther Toxicol 1986;24:609-613.
40. Edwards JW, Priestly BG. Effect of occupational exposure to aldrin on urinary d-glucaric acid, plasma dieldrin, and lymphocyte sister chromatid exchange. Int Arch Occup Environ Health 1994;66:229-234.
41. Hogue CJ, Brewster MA. The potential of exposure biomarkers in epidemiologic studies of reproductive health. Environ Health Perspect 1991;90:261-269.
42. Bland J, Bralley J, Rigden S. Management of chronic fatigue symptoms by tailored nutritional intervention using a program designed to support hepatic detoxification. Paper presented at: HealthComm, Gig Harbor, WA: 1997.
43. Banerjee R, Zou CG. Redox regulation and reaction mechanism of human cystathionine-beta-synthase: a PLP-dependent hemesensor protein. Arch Biochem Biophys 2005;433:144-156.
44. Bellomo G, Martino A, Richelmi P, et al. Pyridine-nucleotide oxidation, Ca2+ cycling and membrane damage during tert-butyl hydroperoxide metabolism by rat-liver mitochondria. Eur J Biochem 1984;140:1-6.
45. Landaas S. The formation of 2-hydroxybutyric acid in experimental animals. Clin Chim Acta 1975;58:23-32.
46. Dissmann R, Linderer T, Schroder R. Estimation of enzymatic infarct size: direct comparison of the marker enzymes creatine kinase and alpha-hydroxybutyrate dehydrogenase. Am Heart J 1998;135:1-9.
47. Silva AR, Ruschel C, Helegda C, et al. Inhibition of in vitro CO2 production and lipid synthesis by 2-hydroxybutyric acid in rat brain. Braz J Med Biol Res 2001;34:627-631.
48. Imaki M, Kawabata K, Yoshida Y, et al. Evaluation of the effects of various factors on the serum alpha hydroxybutyrate dehydrogenase activity in young females. Appl Human Sci 1995;14:297-302.
49. Kano K, Ichimura T. Increased alpha-hydroxybutyrate dehydrogenase in serum from children with measles. Clin Chem 1992;38:624-627.
50. Chalmers RA, Lawson AM. Organic Acids in Man: The Analytical Chemistry, Biochemistry, And Diagnosis of the Organic Acidurias. Norwell, MA: Chapman and Hall (Kluwer Academic Publishers); 1982.
51. Baral N, Pokhrel S, Lamsal M, et al Utility of gamma-glutamyl transpeptidase and mean corpuscular volume in alcoholic liver disease. Southeast Asian J Trop Med Public Health 2005;36:1007-1010.
52. Han GQ, Qin CY, Shu RH. The analysis of gamma-glutamyl transpeptidase gene in different type liver tissues. World J Gastroenterol 2003;9:276-280.
53. Mayatepek E, Okun JG, Meissner T, et al. Synthesis and metabolism of leukotrienes in gamma-glutamyl transpeptidase deficiency. J Lipid Res 2004;45:900-904.
54. Harding CO, Williams P, Wagner E, et al. Mice with genetic gamma-glutamyl transpeptidase deficiency exhibit glutathionuria, severe growth failure, reduced life spans, and infertility. J Biol Chem 1997;272:12560-12567.
55. Bernier FP, Snyder FF, McLeod DR. Deficiency of 5-oxoprolinase in an 8-year-old with developmental delay. J Inherit Metab Dis 1996;19:367-368.
56. Mayatepek E, Hoffmann GF, Larsson A, et al. 5-Oxoprolinase deficiency associated with severe psychomotor developmental delay, failure to thrive, microcephaly and microcytic anaemia. J Inherit Metab Dis 1995;18:83-84.
57. Njalsson R, Norgren S. Physiological and pathological aspects of GSH metabolism. Acta Paediatr 2005;94:132-137.
58. Larsson A, Mattsson B, Wauters EA, et al. 5-Oxoprolinuria due to hereditary 5-oxoprolinase deficiency in two brothers - a new inborn error of the gamma-glutamyl cycle. Acta Paediatr Scand 1981;70:301-308.
59. Vina JR, Palacin M, Puertes IR, et al. Role of the gamma-glutamyl cycle in the regulation of amino acid translocation. Am J Physiol 1989;257:e916-e922.
60. Shi ZZ, Habib GM, Rhead WJ, et al. Mutations in the glutathione synthetase gene cause 5-oxoprolinuria. Nat Genet 1996;14:361-365.
61. Tailor P, Raman T, Garganta CL, et al. Recurrent high anion gap metabolic acidosis secondary to 5-oxoproline (pyroglutamic acid). Am J Kidney Dis 2005;46:e4-e10.
62. Dempsey GA, Lyall HJ, Corke CF, Scheinkestel CD. Pyroglutamic acidemia: a cause of high anion gap metabolic acidosis. Crit Care Med 2000;28:1803-1807.
63. Liu RM, Dickinson DA. Decreased synthetic capacity underlies the age-associated decline in glutathione content in Fisher 344 rats. Antioxid Redox Signal 2003;5:529-536.
64. Atkuri KR, Mantovani JJ, Herzenberg LA, Herzenberg LA. N-Acetylcysteine - a safe antidote for cysteine/glutathione deficiency. Curr Opin Pharmacol 2007;7:355-359.
65. Janse van Rensburg C, Erasmus E, Loots DT, et al. Rosa roxburghii supplementation in a controlled feeding study increases plasma antioxidant capacity and glutathione redox state. Eur J Nutr 2005;44:452-457.
66. Rojas C, Cadenas S, Lopez-Torres M, et al. Increase in heart glutathione redox ratio and total antioxidant capacity and decrease in lipid peroxidation after vitamin E dietary supplementation in guinea pigs. Free Radic Biol Med 1996;21:907-915.
67. Humphreys BD, Forman JP, Zandi-Nejad K, et al. Acetaminophen-induced anion gap metabolic acidosis and 5-oxoprolinuria (pyroglutamic aciduria) acquired in hospital. Am J Kidney Dis 2005;46:143-146.
68. Mukherjee TK, Mishra AK, Mukhopadhyay S, Hoidal JR. High concentration of antioxidants N-acetylcysteine and mitoquinone-Q induces intercellular adhesion molecule 1 and oxidative stress by increasing intracellular glutathione. J Immunol 2007;178:1835-1844.
69. Yu YM, Ryan CM, Fei ZW, et al. Plasma L-5-oxoproline kinetics and whole blood glutathione synthesis rates in severely burned adult humans. Am J Physiol Endocrinol Metab 2002;282:e247-e258.
70. Metges CC, Yu YM, Cai W, et al. Oxoproline kinetics and oxoproline urinary excretion during glycine- or sulfur amino acid-free diets in humans. Am J Physiol Endocrinol Metab 2000;278:e868-e876.
71. Jackson AA, Badaloo AV, Forrester T, et al. Urinary excretion of 5-oxoproline (pyroglutamic aciduria) as an index of glycine insufficiency in normal man. Br J Nutr 1987;58:207-214.
72. Meakins TS, Persaud C, Jackson AA. Dietary supplementation with L-methionine impairs the utilization of urea-nitrogen and increases 5-L-oxoprolinuria in normal women consuming a low protein diet. J Nutr 1998;128:720-727.
73. Oberholzer VG, Wood CB, Palmer T, Harrison BM. Increased pyroglutamic acid levels in patients on artificial diets. Clin Chim Acta 1975;62:299-304.
74. Hsu JM, Anthony WL. Zinc deficiency and urinary excretion of taurine-35S and inorganic sulfate-35S following cystine-35S injection in rats. J Nutr 1970;100:1189-1195.
75. Levy G. Sulfate conjugation in drug metabolism: role of inorganic sulfate. Fed Proc 1986;45:2235-2240.
76. Gregus Z, White C, Howell S, Klaassen CD. Effect of glutathione depletion on sulfate activation and sulfate ester formation in rats. Biochem Pharmacol 1988;37:4307-4312.
77. Magee EA, Curno R, Edmond LM, Cummings JH. Contribution of dietary protein and inorganic sulfur to urinary sulfate: toward a biomarker of inorganic sulfur intake. Am J Clin Nutr 2004;80:137-142.